Abstract Danshensu (DSS), a water-soluble phenolic acid derived from Salvia miltiorrhiza, exhibits antioxidant and osteoprotective properties; however, its effects on type 2 diabetes-related osteoporosis (T2DOP) have not been fully defined. We therefore evaluated the effects of DSS on T2DOP and examined whether PI3K/AKT/Nrf2 signaling participates in its actions. Potential molecular targets and signaling pathways associated with DSS were first screened through a network pharmacology approach.